Non-Hodgkin's lymphomas clinical practice guidelines in oncology Review uri icon

Overview

MeSH Major

  • Lymphoma, Non-Hodgkin

abstract

  • Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval. © Journal of the National Comprehensive Cancer Network.

authors

publication date

  • March 2010

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 20202462

Additional Document Info

start page

  • 288

end page

  • 334

volume

  • 8

number

  • 3